Online advertising for life science companies: which platforms work and why
Paid advertising in life sciences operates under a different set of constraints from most B2B sectors. The audience is small and specialist. The buying process is long and committee-driven. And the return on a campaign is often invisible until months after the spend.
That does not mean advertising does not work. It means the choice of platform, objective, and audience definition matters more than it does in sectors where you can afford to cast a wide net and optimise from volume. This blog covers the three platforms most relevant to life science companies, what each one is genuinely useful for, and how to think about budget and timing.
Table of contents
Why platform choice matters more in life sciences
In most B2B sectors, the paid advertising playbook is reasonably consistent: run Google Ads for search intent, use LinkedIn for professional awareness, and test Meta for retargeting. The volume of potential buyers is large enough that you can run broad campaigns and let the data tell you what works.
Life science B2B does not work that way. The total addressable audience for most life science products or services is measured in hundreds or thousands of decision-makers globally, not hundreds of thousands. A procurement director at a CRO, a principal scientist at a biotech, or a head of BD at a medtech company is not a demographic segment you can reach efficiently with mass-market targeting.
The practical consequence is that wasted impressions cost more, in relative terms, than they do in larger markets. Every EUR spent reaching someone who will never be a relevant buyer is a EUR not spent reaching someone who will. Platform selection and audience definition are the most important decisions in a life science advertising programme, more so than creative execution.
LinkedIn Ads
LinkedIn is the primary paid advertising platform for most life science B2B companies, for one straightforward reason: it is the only platform that allows you to target by professional identity with sufficient precision to reach a small, specialist audience efficiently.
LinkedIn’s targeting options include job title, seniority, company industry, company size, and geography. For a life science company targeting principal scientists at CROs with over 50 employees in Europe, that combination gets you to a reasonably clean audience. No other advertising platform offers that degree of professional targeting.
LinkedIn Ads work best for three specific objectives in life sciences: building brand awareness with a defined set of target accounts or job functions, promoting high-value content to audiences who are in the consideration phase, and supporting specific commercial moments such as a product launch, a conference, or a new market entry.
The limitation is cost. LinkedIn CPCs are among the highest of any digital advertising platform. For meaningful reach with a defined professional audience, a minimum monthly budget of EUR 1,500 to 2,000 is typically required to generate enough data to optimise campaigns effectively. Below that threshold, the data is too thin to make reliable decisions.
LinkedIn Ads are not a lead generation tool in the traditional sense for most life science companies. A BD director at a large pharma company is not going to click a LinkedIn ad and fill in a contact form. What LinkedIn Ads do is build the familiarity and credibility that makes direct outreach and referrals more likely to convert.
Google Ads
Google Ads work on a fundamentally different principle from LinkedIn. Where LinkedIn targets by who someone is, Google targets by what someone is looking for at the moment of the search. That distinction matters for how and when you use it.
For life science companies, Google Ads are most useful in two scenarios. The first is when you are competing for search terms that have clear commercial intent and where you are not yet ranking organically. If someone searches “bioanalytical CRO Europe” and your company is not on page one, a Google Ad puts you there while your SEO programme matures.
The second scenario is protecting your brand. If competitors are running ads against your company name or product terms, brand protection campaigns ensure that searches for your company lead to your site rather than a competitor’s.
Google Ads are less effective for life science companies in the awareness phase. The search volume for most specialist life science terms is too low to generate meaningful traffic from paid search alone, and the cost per click for competitive terms can be high. SEO is generally a better long-term investment for most specialist search terms in this sector.
For Google Ads, budgets can be lower than LinkedIn to get started. EUR 500 to 1,000 per month is enough to test a focused keyword set, provided the targeting is tight and the landing page is relevant to the search intent.
Meta (Facebook and Instagram)
Meta is the least commonly used paid advertising platform for life science B2B, and for most companies it is not the right starting point. The professional targeting capabilities are significantly weaker than LinkedIn, and the context in which people use Facebook and Instagram is not typically one in which they are making professional purchasing decisions.
There are specific use cases where Meta works in life sciences. Conference and event promotion, where you want to reach a defined geographic audience in the days before a trade show, can work well on Meta because the targeting by location and interest is sufficient for that objective. Employer branding and recruitment campaigns can also be effective, particularly for reaching life scientists who are not actively searching for roles but might be open to them.
For most core commercial objectives in life science B2B, Meta should not be the first or second platform you invest in. LinkedIn and Google cover the territory more efficiently for those objectives.
How to think about paid advertising relative to organic
Paid advertising and organic marketing serve different functions and work on different timescales. Organic channels, primarily SEO and LinkedIn content, compound over time and produce results that persist after the investment stops. Paid advertising produces results while the spend is active and stops when the budget stops.
The most effective approach for most life science companies is to treat paid advertising as a complement to an existing organic programme. Paid search closes the gap while SEO rankings develop. LinkedIn Ads extend the reach of content that is already performing well organically. This sequencing typically produces better returns than investing in paid advertising before the organic foundation is in place.
Paid advertising that builds awareness and familiarity before the commercial conversation starts can influence which vendor gets contacted first. That is the mechanism through which advertising creates commercial value in life sciences.
For a broader view of how to allocate a life science marketing budget across paid and organic channels, the life science marketing budget blog covers the trade-offs in more depth.
What to measure
The temptation in paid advertising is to optimise for metrics that are easy to measure: clicks, impressions, cost per click. In life sciences, those metrics are weak proxies for commercial impact because the buying journey is too long and too committee-driven for a click to predict a sale.
More useful metrics for life science advertising programmes include: reach within defined target accounts or job functions, engagement rates on promoted content from relevant audience segments, and the proportion of new website visitors from paid channels who visit multiple pages or return to the site.
The honest assessment is that attribution in life science B2B advertising is inherently imperfect. A campaign that builds awareness with the right people over six months may contribute to a commercial conversation that starts a year later, and that contribution will not show up in a last-click attribution model. Building internal consensus around that reality before you invest is more valuable than searching for a measurement framework that produces clean numbers.
Questions or need guidance? Send us a message, we’re happy to help!
Any questions about life sciences marketing?
Let's talk!
Frequently asked questions about online advertising for life science companies
Which advertising platform works best for life science companies?
For most life science B2B companies, LinkedIn Ads is the primary platform because of its professional targeting capabilities. Google Ads is useful for capturing commercial search intent and protecting your brand. Meta is relevant for event promotion and employer branding but is not the right platform for most core commercial objectives in life science B2B.
How much should a life science company spend on paid advertising?
For LinkedIn Ads, a minimum of EUR 1,500 to 2,000 per month is typically needed to generate enough data to optimise effectively. For Google Ads, EUR 500 to 1,000 per month can be enough to test a focused keyword set. The right budget depends on your objectives, your total audience size, and how advertising fits into your broader marketing programme.
When is the right time to start paid advertising?
Paid advertising works best when it complements an existing organic foundation. If your website does not communicate clearly, your LinkedIn presence is inactive, and you have no content for visitors to engage with, paid advertising will drive traffic to a destination that does not convert. Building the organic foundation first and using paid advertising to extend its reach is generally a more effective sequencing.
How do you measure the ROI of advertising in life sciences?
Clean ROI measurement is difficult in life science B2B advertising because the buying journey is long, multi-stakeholder, and partly invisible to attribution tools. Useful metrics include reach within defined target accounts, engagement rates from relevant audience segments, and pipeline progression among companies that have been exposed to paid campaigns. Accepting imperfect attribution and focusing on directional signals is more productive than seeking a precise return figure.
References
- 6sense 2025 Buyer Experience Report, 4,000+ B2B buyers. https://6sense.com/science-of-b2b/buyer-experience-report-2025/
- Edelman and LinkedIn, “Reaching Beyond the Ready: 2024 B2B Thought Leadership Impact Report,” 2024. https://www.edelman.com/expertise/Business-Marketing/2024-b2b-thought-leadership-report
- Gartner, “The New B2B Buying Journey.” https://www.gartner.com/en/sales/insights/b2b-buying-journey
